Wyatt, C. M., Chaudhari, J., Miao, S., Krishnasami, Z., Hellinger, J., Levey, A. S., … Inker, L. A. (2020). Ritonavir-Boosted Protease Inhibitors Do Not Significantly Affect the Performance of Creatinine-Based Estimates of GFR. Kidney Int Rep, 5(5), 734–737. https://doi.org/10.1016/j.ekir.2020.01.020

Wyatt, Christina M., Juhi Chaudhari, Shiyuan Miao, Zipporah Krishnasami, James Hellinger, Andrew S. Levey, Michael Ross, et al. “Ritonavir-Boosted Protease Inhibitors Do Not Significantly Affect the Performance of Creatinine-Based Estimates of GFR.” Kidney Int Rep 5, no. 5 (May 2020): 734–37. https://doi.org/10.1016/j.ekir.2020.01.020.

Wyatt CM, Chaudhari J, Miao S, Krishnasami Z, Hellinger J, Levey AS, et al. Ritonavir-Boosted Protease Inhibitors Do Not Significantly Affect the Performance of Creatinine-Based Estimates of GFR. Kidney Int Rep. 2020 May;5(5):734–7.

Wyatt, Christina M., et al. “Ritonavir-Boosted Protease Inhibitors Do Not Significantly Affect the Performance of Creatinine-Based Estimates of GFR.” Kidney Int Rep, vol. 5, no. 5, May 2020, pp. 734–37. Pubmed, doi:10.1016/j.ekir.2020.01.020.

Wyatt CM, Chaudhari J, Miao S, Krishnasami Z, Hellinger J, Levey AS, Ross M, Ryom L, Mocroft A, Brunet L, Fusco J, Inker LA. Ritonavir-Boosted Protease Inhibitors Do Not Significantly Affect the Performance of Creatinine-Based Estimates of GFR. Kidney Int Rep. 2020 May;5(5):734–737.